Overview

Irbesartan Versus Amlodipine: The OBI Study

Status:
Withdrawn
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Objective: 1. To study the effectiveness of irbesartan 300mg and amlodipine 10 mg in 24h ambulatory blood pressure values in obese subjects 2. To study the drug specific effect in arterial stiffness 3. To study possible drug mechanisms in obesity (reduction of central adiposity and changing the ratio of leptin to adiponectin)
Phase:
Phase 4
Details
Lead Sponsor:
Aristotle University Of Thessaloniki
Treatments:
Amlodipine
Hydrochlorothiazide
Irbesartan